CatalystMacro

Protein degrader drug developer Lycia seeks $228M in U.S. IPO

Lycia seeks $228M U.S. IPO for protein degrader drugs.

What changed

Lycia seeks $228M U.S. IPO for protein degrader drugs.

Why it matters

Lycia seeks $228M U.S. IPO for protein degrader drugs. — impact context not separately stored; see What changed.

Sources